Competition Grows In Claudin18.2 As AstraZeneca Seals Antibody Conjugate Deal
Chasing Astellas In Gastric Cancer
Already a major player in the field thanks to Enhertu, AstraZeneca is doubling down in gastric cancer with the new antibody-drug conjugate deal with China’s KYM Biosciences.
